{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:06:21Z","timestamp":1761217581025},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T00:00:00Z","timestamp":1348531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>Rheumatoid arthritis (<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>) is a chronic inflammatory disorder of the synovium resulting in the destruction of affected joint cartilage and bone structures. Etanercept is a biological agent that blocks the tumor necrosis factor\u2010\u03b1 (<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1)\u2010mediated inflammatory processes in <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients, and has a regenerative effect on cartilage. In order to identify novel disease\u2010related proteins and candidate biomarkers, we performed proteomic profiling of the serum in patients with <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> who were treated with etanercept.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Serum samples were obtained from eight <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients before and after etanercept treatment. The low molecular weight proteins in the serum were concentrated and analyzed by liquid chromatography\u2010tandem mass spectrometry. The results before and after etanercept treatment were compared by the spectrum count method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among a total of 477 proteins identified, 12 were found to be decreased and five were increased by etanercept treatment. Some of the changed proteins were known to be related to <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>, and most of the other changed proteins may play possible roles in the <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1 signaling pathway or the state of cartilage and extracellular matrix.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The present proteomic study identified several proteins that could be involved in the pathogenesis of <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>. These findings could thus lead to the identification of novel candidate disease\u2010related protein biomarkers for <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>, or indicate new targets for therapy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1756-185x.2012.01816.x","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T21:05:05Z","timestamp":1348607105000},"page":"486-495","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor\u2010alpha receptor"],"prefix":"10.1111","volume":"15","author":[{"given":"Mitsuaki","family":"Yanagida","sequence":"first","affiliation":[{"name":"Institute for Environmental and Gender Specific Medicine Juntendo University Graduate School of Medicine Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giman","family":"Jung","sequence":"additional","affiliation":[{"name":"New Frontiers Research Laboratories Toray Industries, Inc. Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Tanaka","sequence":"additional","affiliation":[{"name":"New Frontiers Research Laboratories Toray Industries, Inc. Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saburo","family":"Sone","sequence":"additional","affiliation":[{"name":"Head Office Toray Industries, Inc. Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Fujishiro","sequence":"additional","affiliation":[{"name":"Institute for Environmental and Gender Specific Medicine Juntendo University Graduate School of Medicine Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Institute for Environmental and Gender Specific Medicine Juntendo University Graduate School of Medicine Chiba Japan"},{"name":"Department of Internal Medicine Juntendo University Urayasu Hospital Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Nozawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Kohnodai Hospital National Center for Global Health and Medicine Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Takasaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology Juntendo University School of Medicine Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideoki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Institute for Environmental and Gender Specific Medicine Juntendo University Graduate School of Medicine Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Takamori","sequence":"additional","affiliation":[{"name":"Institute for Environmental and Gender Specific Medicine Juntendo University Graduate School of Medicine Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Sekigawa","sequence":"additional","affiliation":[{"name":"Institute for Environmental and Gender Specific Medicine Juntendo University Graduate School of Medicine Chiba Japan"},{"name":"Department of Internal Medicine Juntendo University Urayasu Hospital Chiba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,25]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1995.tb00070.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.2008.i70"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.3.1548"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.5.5.683"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu1029oa"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707173370301"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1995.0029"},{"key":"e_1_2_7_9_1","first-page":"261","article-title":"Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti\u2010tumor necrosis factor\u2010alpha antibody therapy","volume":"26","author":"Sekigawa I","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2863"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201000069"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2637"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1949.02900430001001"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200500774"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac034120b"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac0498563"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M500061-MCP200"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M300031-MCP200"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R200007-MCP200"},{"key":"e_1_2_7_23_1","first-page":"163","volume-title":"Riumachi\u2010byo seminar","author":"Eguchi Y","year":"2006"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01972199"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206406"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202937200"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-0266(00)00040-1"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23495"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22321"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod42.2.317"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27491"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1694"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2706"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2012.01816.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1756-185X.2012.01816.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:27:16Z","timestamp":1698780436000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2012.01816.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,25]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1111\/j.1756-185X.2012.01816.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2012.01816.x","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,25]]},"assertion":[{"value":"2012-09-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}